YMRC
DXCM icon

Yorktown Management & Research Company’s DexCom DXCM Stock Holding History

Yorktown Management & Research Company’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,320
Closed -$311K – 235
2021
Q4 		$311K Hold
2,320
– – 0.21% 177
2021
Q3 		$317K Hold
2,320
– – 0.24% 165
2021
Q2 		$248K Buy
+2,320
New +$223K 0.19% 218
2014
Q2 		– Sell
-28,400
Closed -$294K – 488
2014
Q1 		$294K Hold
28,400
– – 0.06% 203
2013
Q4 		$251K Buy
+28,400
New +$225K 0.05% 296

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Yorktown Management & Research Company's DXCM Position: Q1 2022 in Review

Yorktown Management & Research Company sold out of DexCom (DXCM) in Q1 2022, closing a stake of 2,320 shares — an estimated $311K sold.

Yorktown Management & Research Company first reported a position in DXCM in Q4 2013 and held it in 5 quarters. The position peaked at $317K in Q3 2021. 861 funds tracked by Wall St. Rank hold DXCM as of Q1 2022.

  • Yorktown Management & Research Company reported no remaining DexCom position as of Q1 2022 after selling out during the quarter.
  • Yorktown Management & Research Company sold 2,320 DexCom shares in Q1 2022, an estimated $311K.
  • Yorktown Management & Research Company first reported a position in DexCom in Q4 2013 and held it in 5 quarters.
  • Yorktown Management & Research Company's DexCom position peaked at $317K in Q3 2021.
  • 861 funds tracked by Wall St. Rank held DexCom as of Q1 2022.

Based on Yorktown Management & Research Company's 13F filing for Q1 2022, filed 29 Apr 2022.